Go to the list of all blogs
published in Blogs
Aug 04, 2026
Netflix (NFLX) Drops -10.9% in 30 Days After Q2 Results and Guidance Concerns

Netflix (NFLX) Drops -10.9% in 30 Days After Q2 Results and Guidance Concerns

Key Takeaways

  • Netflix shares fell approximately 10.9% over the last 30 days, driven primarily by a post-earnings selloff following Q2 2026 results released on July 16.
  • Q2 revenue of $12.56 billion narrowly missed consensus estimates, and Q3 guidance of $12.86 billion came in below Wall Street's expected $13 billion, triggering at least 20 analyst price-target cuts.
  • Management's decision to reduce engagement reporting from semi-annual to annual starting in 2027 rattled investors already concerned about slowing viewing-hour growth and decelerating revenue trends.
  • The stock is now trading roughly 46% below its 52-week high, with forward P/E ratios compressing to levels not seen since 2022, reflecting broader skepticism around the streaming giant's growth trajectory.
  • Despite near-term headwinds, Netflix's advertising business remains on track to double to approximately $3 billion in 2026, and the company executed a record $4.7 billion in share buybacks during the quarter.

Netflix (NFLX) Company Overview and Market Position

Netflix, Inc. remains the world's largest premium subscription streaming service, with more than 325 million paid subscribers globally as of year-end 2025. The company pioneered the direct-to-consumer model and has expanded into original content, advertising tiers, live events, gaming, and short-form video. It competes with platforms from DIS, AMZN, WBD, and SPOT, yet holds a clear lead in global engagement and brand strength. I closely track NFLX for its ability to sustain revenue growth, expand margins, and generate free cash flow amid rising competition. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Netflix (NFLX) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 calendar days, NFLX shares declined approximately 10.9%, falling from a closing price of $77.38 on June 18, 2026, to $68.95 on July 17, 2026. Most of the drop came in one session on July 17, when the stock fell 7.6% after the Q2 report and softer Q3 outlook. Intraday, shares touched a two-year low near $65.08.

Looking back across the quarter, the stock entered near $107 in mid-April and has since declined roughly 36%. This reflects earlier setbacks such as the failed Warner Bros. Discovery acquisition, a lost bid for Roku, and growing worries over slowing engagement and revenue momentum. The shares now sit about 46% below the 52-week high of $127.75 reached in July 2025.

What Drove NFLX Stock Price in the Last 30 Days

The main catalyst was the Q2 2026 earnings release after the close on July 16. Revenue of $12.56 billion (up 13% year-over-year) and EPS of $0.80 came in close to or slightly above estimates, yet investors focused on the outlook. Management guided Q3 revenue to $12.86 billion and EPS to $0.82, both below consensus of $13 billion and $0.84. Growth is expected to slow to 11.7% in Q3 from 13.4% in Q2 and rates above 17% late last year.

Adding to the disappointment, Netflix said it will move its “What We Watched” engagement report from semi-annual to annual starting in 2027. Analysts viewed the reduced transparency negatively after the earlier decision to stop quarterly subscriber updates. Viewing hours rose just 2% in the first half of 2026. Free cash flow also fell to $1.53 billion from $2.27 billion a year earlier, partly due to higher cash taxes linked to the Warner Bros. termination fee. These factors prompted price-target reductions from firms including JPMorgan, Barclays, Wells Fargo, Pivotal Research, TD Cowen, and Goldman Sachs. From what I see, the combination of softer guidance and less visibility weighed heavily on sentiment.

What Drove NFLX Stock Performance Over the Last Quarter

The broader quarterly decline stems from a narrative shift that began earlier. In late 2025 and early 2026, the company pursued a major acquisition of Warner Bros. Discovery assets that ultimately fell through, raising questions about strategic direction. It also lost a roughly $22 billion bid for Roku. The departure of co-founder Reed Hastings added another layer of uncertainty.

Operationally, revenue growth has slowed from above 17% in the second half of 2025 to 13.4% in Q2 2026, with further deceleration expected. Q1 results beat on revenue but offered no upward revision to full-year guidance, which the market read as acknowledgment of a tougher growth path ahead. Institutional investors have trimmed positions for three straight quarters. The stock now trades at roughly 18-21 times forward earnings, a level that reflects recalibrated expectations rather than an obvious bargain.

NFLX Stock Forecast Drivers: What Investors Should Watch Next

Several upcoming factors will shape whether NFLX can stabilize. The short-form content launch on August 3 directly targets competition from platforms like YouTube and TikTok. The Women’s World Cup, for which Netflix holds exclusive U.S. rights, offers a live-event opportunity that could boost subscribers and advertising demand in the second half of the year.

Investors will want to see whether Q3 results meet or fall short of guidance, as another miss could deepen concerns about structural slowdown. The advertising business, aiming for roughly $3 billion in 2026 revenue, remains key to longer-term margin growth. Clarity on M&A plans, content spending, and AI integration in production and personalization will also matter. Macro conditions, consumer spending, and currency moves deserve attention given the company’s large international exposure. I’m watching this closely as the next few quarters unfold.

Exploring AI Tools for Market Analysis

In my research process, I often turn to Tickeron’s AI tools to cross-check signals and compare performance across sectors. The AI Trading Bots section provides a practical way to review automated strategies that align with different timeframes and objectives. It helps me stay objective when evaluating names like NFLX amid shifting fundamentals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NFLX

NFLX in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 17, 2026

NFLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where NFLX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NFLX's RSI Indicator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on NFLX as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NFLX just turned positive on July 27, 2026. Looking at past instances where NFLX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NFLX advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NFLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NFLX entered a downward trend on July 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NFLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NFLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.246) is normal, around the industry mean (20.961). P/E Ratio (23.333) is within average values for comparable stocks, (103.027). Projected Growth (PEG Ratio) (1.661) is also within normal values, averaging (14.008). NFLX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (6.601) is also within normal values, averaging (2.984).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Netflix Inc. (NASDAQ:NFLX), Walt Disney Company (The) (NYSE:DIS), Roku (NASDAQ:ROKU), Paramount Skydance Corporation (NASDAQ:PSKY), AMC Entertainment Holdings (NYSE:AMC), iQIYI (NASDAQ:IQ), HUYA (NYSE:HUYA).

Industry description

Movies/entertainment industry include companies that produce and distribute motion pictures, and companies that operate general entertainment facilities like amusement parks and bowling centers. Some companies in this industry also have professional sports franchises. Live Nation Entertainment, Inc., Liberty Media Corp. and Viacom Inc. are some of the biggest companies in this space.

Market Cap

The average market capitalization across the Movies/Entertainment Industry is 17.25B. The market cap for tickers in the group ranges from 134 to 308.96B. NFLX holds the highest valuation in this group at 308.96B. The lowest valued company is LRDG at 134.

High and low price notable news

The average weekly price growth across all stocks in the Movies/Entertainment Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 11%. MCS experienced the highest price growth at 23%, while KWM experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Movies/Entertainment Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was -22% and the average quarterly volume growth was -47%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 52
Price Growth Rating: 56
SMR Rating: 84
Profit Risk Rating: 76
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
NFLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of online movie rental subscription services

Industry MoviesEntertainment

Profile
Details
Industry
Cable Or Satellite TV
Address
121 Albright Way
Phone
+1 408 540-3700
Employees
16000
Web
https://www.netflix.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.